Physician profile
Daniel J Donovan
NPI 1730150160
$22,648.92
in general payments reported to CMS, 2019-2025
34 companies · $3,190 in 2025
The $3,190 reported for 2025 was more than what 76% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,987 · 2020: $2,120 · 2021: $1,661 · 2022: $4,363 · 2023: $4,031 · 2024: $3,297 · 2025: $3,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,037 · Travel and Lodging: $2,199 · Long Term Medical Supply Or Device Loan: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,036.69 |
| Travel and Lodging | $2,199.36 |
| Long Term Medical Supply Or Device Loan | $281.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,305.94 | 2021-2025 | Corevalve Evolut R |
| Abbott Laboratories | $4,649.11 | 2019-2025 | Triclip, Portico, Navitor |
| Medtronic Vascular, INC. | $2,405.64 | 2019-2020 | |
| Edwards Lifesciences Corporation | $1,428.33 | 2019-2025 | Sapien 3 Ultra Resilia, Evoque |
| Philips North America LLC | $1,231.52 | 2023 | (9520) Igt Devices Und |
| Abiomed | $942.91 | 2021-2025 | Impella |
| Boston Scientific Corporation | $521.56 | 2019-2025 | Cds - Mct/Cem Monitoring, Watchman Access System, Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $476.38 | 2019-2025 | Camzyos, Eliquis |
| Angiodynamics, INC. | $174.83 | 2025 | Angiovac |
| Novartis Pharmaceuticals Corporation | $142.82 | 2019-2025 | |
| Pfizer INC. | $112.62 | 2019-2025 | |
| Cvrx, INC. | $112.57 | 2025 | Barostim Neo System |
| Novo Nordisk INC | $106.35 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $100.57 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $88.87 | 2021-2023 | Onpattro |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $88.30 | 2021-2024 | Nexletol |
| Biostable Science & Engineering | $84.07 | 2019 | |
| Merck Sharp & Dohme LLC | $77.46 | 2021-2022 | |
| Glaxosmithkline, LLC. | $65.78 | 2023-2025 | Shingrix, Arexvy |
| Ancora Heart, INC. | $60.72 | 2023 | Accucinch |
| Preventice Services, LLC | $56.74 | 2021 | |
| Amgen INC. | $50.70 | 2019-2025 | Repatha |
| Sanofi-Aventis U.S. LLC | $47.78 | 2021-2023 | |
| Acist Medical Systems, INC. | $47.50 | 2024 | |
| Osprey Medical INC | $46.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.09 | 2019-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $35.69 | 2024 | Arcalyst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.62 | 2023 | Lifevest |
| Kiniksa Pharmaceuticals, LTD. | $26.10 | 2023 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $25.32 | 2019 | |
| Teleflex LLC | $23.58 | 2024 | R350 |
| Irhythm Technologies, INC. | $14.72 | 2021 | |
| Scpharmaceuticals INC. | $14.02 | 2023 | |
| Avinger INC. | $13.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Donovan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.